title: [5-phosphodiesterase inhibitors and cardiovascular risk].
authors.affiliation: Urologie, hôpital Nord, CHU de St-Priest-en-Jarez, avenue Albert Raimond, 42277 St-Priest-en-Jarez cedex, France. jacques.tostain@chu-st-etienne.fr
authors.forename: J
authors.initials: J
authors.lastname: Tostain
mesh_terms: D002243:Carbolines / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D006801:Humans; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D012307:Risk Factors; D000068581:Tadalafil
chemical_list: D002243:Carbolines; D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors; D000068581:Tadalafil